Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by mediascan59on May 16, 2010 10:08am
485 Views
Post# 17103428

RE: Gain, retrace, gain, retrace

RE: Gain, retrace, gain, retraceResponse to Fattums.
Your numbers are very good.
 If you look at the movement on SSS for 2010, there were seven nice pops for this stock, each averaging approximately a 27% movement upward before settling down.
Your targets of .65 and .86 match mine as well and if I were to extrapolate your 1.15, 1.65 and then 2.50 and do  all their averages, they each follow the same average gain of 27%.
History repeats itself, markets repeat themselves, the mathematics repeats itself thus the reason for the large use of TA to determine price points.
Does the time frame repeat itself?
Does it mean that come the end of 2010, this stock is sitting at $2.50 per share?
The math says yes.
 All we need are positive results from Phase11b and we will be on our way.
This stock is a recommended buy by Dundee, CIBC and others.
You really cannot put anymore ducks in a row and not end up being successful in this play.
The uncertainty in what the results will reveal has been to our advantage in order to pick up large amounts of this stock.
The insiders, of whom have stock options at a fraction of today's prices have not sold a single share and opted to take shares in lieu of wages. That also speaks volumes and may actually be the biggest hint of all our fundamental investigations.
If the numbers come out positive, this will change the world and how we deal with not only strokes, ms, tbi, etc, but so many other areas we have not been able to touch up until this year.
The markets will recognize this company for what it has accomplished and it will reward it, and everyone will want a piece of it.
So sit back, make a bowl of popcorn and enjoy the show while your personal wealth goes beyond your expectations.

Mediascan
Bullboard Posts